NIV FOR COPD: USING END-TIDAL CO2 TO IDENTIFY PATIENTS WHO BENEFIT By Dave Lyman, Vice President of Respiratory and Sales, VGM & Associates
![]()
NIV FOR COPD: USING END-TIDAL CO2 TO IDENTIFY PATIENTS WHO BENEFIT By Dave Lyman, Vice President of Respiratory and Sales, VGM & Associates